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The first-night effect—marked differences between the first- and the second-night sleep spent in a
laboratory—is a widely known phenomenon that accounts for the common practice of excluding
the first-night sleep from any polysomnographic analysis. The extent to which the first-night effect
is present in a participant, as well as its duration (1 or more nights), might have diagnostic value
and should account for different protocols used for distinct patient groups. This study investigated
the first-night effect on nightmare sufferers (NM; N D 12) and healthy controls .N D 15/ using
both objective (2-night-long polysomnography) and subjective (Groningen Sleep Quality Scale
for the 2 nights spent in the laboratory and 1 regular night spent at home) methods. Differences
were found in both the objective (sleep efficiency, wakefulness after sleep onset, sleep latency,
Stage-1 duration, Stage-2 duration, slow-wave sleep duration, and REM duration) and subjective
(self-rating) variables between the 2 nights and the 2 groups, with a more pronounced first-night
effect in the case of the NM group. Furthermore, subjective sleep quality was strongly related to
polysomnographic variables and did not differ among 1 regular night spent at home and the second
night spent in the laboratory. The importance of these results is discussed from a diagnostic point
of view.
A phenomenon that all polysomnographic sleep studies—basic or clinical—encounter is the
first-night effect—a marked difference between sleep quality of the first and second night spent
in the sleep laboratory. Distinct patient groups—in addition to their altered sleep patterns—can
also show first-night effect to a different extent. Based on this argument and due to the lack
of data available on the first-night effect in different clinical populations, this study aims to
investigate this effect by combining objective and subjective methods in nightmare sufferers
(NM) and healthy controls (CO).
The first-night effect refers to a set of differences observed on the first recording, compared
to consecutive ones—most commonly, the second one (Agnew, Webb, & Williams, 1966).
Specifically, compared to the recordings of the second night, first-night sleep is characterized
by decreased total sleep time and reduced REM sleep, lower sleep efficiency, more intermittent
wake time, longer REM latency, and an increased amount of Stage-1 (S1) sleep (Curcio, Ferrara,
Piergianni, Fratello, & De Gennaro, 2004). The origins of this effect can be attributed to
multiple reasons: unfamiliar environment, discomfort, limitations of movements because of the
electrodes and cables, and the psychological consequences of “being under investigation” (Bon
et al., 2003; Tamaki, Nittono, Hayashi, & Hori, 2005).
As the first-night effect is a direct consequence of the objective—polysomnographic—sleep
assessment along with the laboratory setting, it has scarcely been investigated by subjective
measures, such as self-rating questionnaires, indexing sleep quality. Furthermore, the compar-
ison of subjective reports and objective (polysomnographic) measurements of different sleep
parameters, in general, has only been done in a very few studies. Whereas the first such
study (Johns, 1975) found that objective and subjective measures were related, more recent
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studies found a marked discrepancy between the two measures (Philipsen et al., 2005)—for
instance, regarding the length of sleep and the latency of sleep onset (e.g., Silva et al., 2007).
Moreover, in a recent study (Moser, Kloesch, Fischmeister, Bauer, & Zeitlhofer, 2010) on
healthy participants, the first-night effect was not detected by the examination of subjective
sleep variables in contrast to the objective ones.
Because of the observed differences between the first and the consecutive night spent
in the sleep laboratory, it is common practice to exclude the first-night recording from any
polysomnographic analysis (Mendels & Hawkins, 1967). Although most differences have been
observed by comparing the first and the second night, it has also been shown that residual effects
are present beyond the second night (Le Bon et al., 2001), and this can question the validity of
the data recorded even on the second night. This issue might be addressed when investigating
different psychiatric disorders because—although no such systematic analysis has been carried
out—it has been suggested that each medical condition might influence the first-night effect in
different ways (Newell, Mairesse, Verbanck, & Neu, 2012). This idea is supported by a few
studies providing evidence that, for example, patients with sleep apnea disorders (Le Bon et al.,
2000) and idiopathic NM individuals (Nielsen et al., 2010) manifest a stronger first-night effect.
In contrast, patients suffering from depression (Toussaint et al., 1995), insomnia (Edinger et al.,
1997; Edinger et al., 2001), or posttraumatic stress disorder (PTSD; Saletu et al., 1996) manifest
a less-pronounced first-night effect. Given that the medical conditions may affect the magnitude
of the first-night effect, stronger and longer first-night effects might also bias the observed
differences in the characteristics of the second-night sleep as compared to the CO group.
Nightmare disorder is a prevalent parasomnia characterized by vivid and highly unpleasant
dream experiences that frequently end in abrupt awakenings (Spoormaker, Schredl, & van den
Bout, 2006) usually—but not exclusively—from REM sleep with a clear recall of the disturbing
mentation. Idiopathic nightmares are distinguished from posttraumatic nightmares (which are
necessarily associated with PTSD) and sleep terrors (which typically arise from non-REM
sleep with no clear recall of the dream). Although questionnaire-based studies have shown
that nightmares are related to impaired sleep quality (Lancee, Spoormaker, & van den Bout,
2010; Li, Zhang, Li, & Wing, 2010; Schredl, 2003), and NM participants exhibit significantly
worse values on sleep- and health-related indexes (Krakow, 2006), the sleep architecture of
NM individuals has scarcely been investigated. After the first inconclusive results (Fisher,
Bryne, Edwards, & Kahn, 1970; Germain, & Nielsen, 2003), a recent study (Simor, Horváth,
Gombos, Takács, & Bódizs, 2012) found that NM participants are characterized by altered
sleep architecture showing impaired sleep continuity and emotion-related increases in REM
propensity reflected by reduced sleep efficiency, increased wakefulness, a reduced amount of
slow-wave sleep (SWS), and an increased number of nocturnal awakenings, especially from
Stage-2 (S2) sleep.
The main goal of this study was to investigate the first-night effect in NM and CO participants
by combining objective and subjective methods. Our aim was to compare the macrostructural
sleep parameters between the first and the second night spent in the laboratory in NM and
CO groups; and, in addition, to reveal possible interactions between the two factors (Night 
Group). We were also interested to see whether a relation existed between the two types of data
(objective and subjective) regarding sleep quality. Furthermore, to determine whether the first-
night effect is still present during the second night spent in the sleep laboratory, we compared
subjective ratings of sleep quality after the laboratory nights with that of 1 night spent at home.
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METHOD
Participants
Participants were selected from a pool of approximately 1,700 university students who had
completed online questionnaires assessing dream quality, including the Dream Quality Ques-
tionnaire (Bódizs, Simor, Csóka, Bérdi, & Kopp, 2008), the Hungarian version of the Van
Dream Anxiety Scale (Simor, Kovács et al., 2009), and a 7-point Likert scale (0 D almost
never, 1 D once or twice per year, 2 D every 2–3 months, 3 D once per month, 4 D twice per
month, 5 D once per week, and 6 D more than once per week) with two items: one assessing
the frequency of nightmares with awakenings and the other assessing the frequency of bad
dreams without awakenings. Inclusion criteria for the NM group were determined on the basis
of the International Classification of Sleep Disorders–Second Edition (American Academy of
Sleep Medicine, 2005) criteria and Levin and Nielsen’s (2007) model of disturbed dreaming,
including disturbed dreamers without abrupt awakenings. Participants reporting one or more
nightmares or bad dreams per week in the retrospective questionnaires were assigned to the
NM group, whereas individuals were assigned to the CO group only if they had less than two
nightmares and bad dreams during the last year. NM participants were thoroughly interviewed
about the frequency and content of their negative dream experiences. Those participants who
reported the onset of negative dream experiences in relation to a traumatic event or indicated
that the content of their dreams was somehow related to a prior trauma (such as physical
attack, accident, sudden death of a close relative, etc.) were excluded from the study. Forty-two
participants, 19 NM (10 men and 9 women; mean age D 20.87 ˙ 1.57 years) and 23 CO (11
men and 12 women; 21.57 ˙ 1.47 years), participated in the 2-night-long polysomnography
recording. Data of 15 participants (7 NM and 8 CO) were excluded from further analysis
in this study due to technical problems (noisy recordings, increased impedance values, and
problems with the reference electrode), especially at the first night. Therefore, finally, the
polysomnographic data of 12 NM (5 men and 7 women; 21:83 ˙ 2:45 years) and 15 CO
(7 men and 8 women; 22:00˙ 2:45 years) participants were analyzed. Participants that were
included in the study did not differ in age from the ones that were excluded: NM, t.17/ D 0:454,
p D :656; CO, t.21/ D 0:621, p D :542; on the State-Trait Anxiety Inventory-Trait anxiety
questionnaire (STAI–T; Sipos, Sipos, & Spielberger, 1994): NM, t.17/ D 0:425, p D :676; CO,
t.21/ D 0:425, p D :676; on the Hungarian version of the Beck Depression Inventory (BDI–
H; Rózsa, Szádóczky, & Füredi, 2001): NM, t.17/ D 1:898, p D :091; CO, t.21/ D 0:097,
p D :924; and Groningen Sleep Quality Scale (Simor, Köteles, Bódizs, & Bárdos, 2009) scores:
NM, t.17/ D 0:092, p D :928; CO, t.21/ D 1:112, p D :280; or in sleep efficiency during
the second night: NM, t.17/ D 0:891, p D :385; CO, t.19/ D 0:808, p D :429.
Procedure
Participants were not allowed to drink alcohol and take drugs (except contraceptives) on
the day and the previous day of the examination. They were asked to avoid napping and
consuming caffeine on the afternoon of the sleep recordings. Participants were asked to fill out
questionnaires upon arrival to the laboratory. The Hungarian version of the 20-item STAI–T
(Sipos et al., 1994) was used to assess general levels of anxiety, and the short form of
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the Hungarian version of the BDI–H (Rózsa et al., 2001) was used to measure the extent
of waking depressive symptoms in our participants. Sleep was recorded in two consecutive
nights by standard polysomnography, including electroencephalography (recording sites: Fp1,
Fp2, F3, F4, Fz, F7, F8, C3, C4, Cz, P3, P4, Pz, T3, T4, T5, T6, O1, and O2), according
to the 10–20 electrode placement system (Jasper, 1958), left and right electrooculography
(EOG), bipolar chin, and leg electromyography (EMG); electrocardiography (ECG); as well as
abdominal and thoracic respiratory movements. The monopolar EEG electrodes were referred
to the mathematically linked mastoids (A1 and A2), whereas the other measurements (EOG,
EMG, and ECG) were bipolar. Impedances for the EEG electrodes were kept below 8 kO.
Signals were collected, pre-filtered (0.33–1,500 Hz, 40 dB/decade anti-aliasing hardware input
filter), amplified, and digitized at a sampling rate of 4,096 Hz/channel by using the 32 channel
EEG/polysystem (Brain-Quick BQ132, Micromed, Mogliano Veneto, Treviso, Italy). A further
40 dB/decade anti-aliasing digital filter was applied by digital signal processing which low pass
filtered the data at 450 Hz. The digitized and filtered EEG was subsequently down-sampled at
1,024 Hz. The timing of lights off was between 11:00 p.m. and 1:00 a.m., as determined by
participants’ usual sleep habits. Morning awakenings were scheduled after 9 hr of undisturbed
sleep, except if participants spontaneously woke up earlier.
In addition, participants had to fill out the Hungarian version of the Groningen Sleep Quality
Scale (Simor, Köteles, et al., 2009) for both nights after awakening the following morning. A
subgroup of the participants (10 NM and 18 CO; 19 of them with a polysomnography recording
for both nights spent in the laboratory) also filled out the Groningen Sleep Quality Scale after
1 regular night spent at home. This questionnaire is a 15-item list of sleep complaints that
gives a global score of sleep quality ranging from 0 to 14, with the maximum indicating poor
sleep quality (Mejiman, de Vries-Griever, & de Vries, 1988).
The research protocols were approved by the ethical committee of the Institute of Behav-
ioral Sciences, Semmelweis University, Budapest. All participants gave informed consent and
received monetary compensation (approximately e20 [$28] in Hungarian Forints for their
participation in the sleep laboratory investigations.
Analysis
Wakefulness and sleep stages of the recordings were manually identified coding 20-sec epochs
according to standardized criteria (Minaritzoglou, & Vagiakis, 2008; Rechtschaffen & Kales,
1968) by four experienced sleep researchers (first night: Anna Kis and Sára Szakadát; second
night: Péter Simor and Klára Horváth) who were blind to the group membership of the
participants. A generalized estimating equation was used to test the effect of night (first or
second in the laboratory) and group (NM or CO) on the following variables: sleep efficiency
(percentage), wake after sleep onset (WASO)—after first-night S1 sleep episode (min); sleep
latency—first non-S1 episode sleep (minutes); relative S1 duration (percentage), relative S2
duration (percentage), relative Stage-3 C Stage-4 (SWS) duration (percentage), relative REM
duration (percentage), and REM latency (minutes). The interaction between Night  Group
was examined to see if there was a differential first-night effect in the two groups.
Subjective sleep qualitywas assessed by the Groningen Sleep Quality Scale. We again tested
the effect of night (first or second in the laboratory and at home) and group (NM or CO) using
6 KIS ET AL.
generalized estimating equations. Furthermore, subjective sleep quality across the groups was
correlated with the sleep variables (applying multinominal logistic regression).
The effect of STAI–T and BDI–H scores on the first-night effect was assessed by using a
general linear model, with the difference between the first and the second night in terms of
the polysomnographic variables and subjective sleep quality as the dependent variables and
STAI–T and BDI–H scores as the covariates in the model.
RESULTS
Data from the polysomnographic recordings indicated that, in accordance with our hypothesis,
sleep was poorer on the first night, showing a more pronounced first-night effect in the case of
the NM group (see Table 1). In the case of some variables, such as sleep efficiency, the main
effect of both factors (night and group) was significant (see Figure 1). In the case of other
variables, such as the relative S2 duration, neither of the two factors influenced the variable;
however, a significant interaction was found among them (see Figure 2).
The results regarding subjective sleep quality were in accordance with polysomnographic
findings (see Figure 3). There was a significant effect of nights spent in the laboratory or at
home, 2(1, N D 27/ D 19:296, p < :001; and group, 2(1, N D 27/ D 6:059, p D :014.
There was no interaction between the two factors, 2(1, N D 27/ D 1:099, p D :577.
Moreover, the subjective Groningen Sleep Quality Scale scores were associated with several
objective sleep measures: sleep efficiency .2 D 21:401; p D :045/, sleep latency .2 D
29:064; p D :004/, S1 duration .2 D 28:481; p D :005/, S2 duration .2 D 31:075; p D
:002/, SWS duration .2 D 28:671; p D :004/, REM duration .2 D 32:364; p D :001/,
and REM latency .2 D 26:525; p D :009/. No correlation was found with WASO .2 D
15:246; p D :228/.
Our data showed that NM patients scored higher than CO participants on both the STAI–T,
t.25/ D 4:855; p < :001; and the BDI–H, t.25/ D 5:770; p < :001. However, a general
linear model, with the difference between the first and the second night in terms of the
polysomnographic variables and subjective sleep quality as dependent variables and STAI–T
and BDI–H scores as covariates, revealed that the scores obtained on the STAI–T and BDI–H
questionnaires did not affect the extent to which the first-night effect was present in the given
participant (p > :05 for all tests).
DISCUSSION
In line with previous research (e.g., Curcio et al., 2004), our study found decreased sleep
duration, lower sleep efficiency, longer WASO and decreased REM duration at the first night
compared to the second, which is in accordance with the well-known phenomenon of the first-
night effect (Agnew et al., 1966). We also found previously unreported differences in the ratio
of S2 and SWS between the first and the second night. Specifically, all participants spent more
time in SWS in the second night, and the NM group also spent relatively more time in S2 in
the second, compared with the first, night. In line with an earlier study on NM participants
TABLE 1
Group and Night Differences Regarding the Polysomnographic Variables
First Night Second Night Main Effect Interaction
Variable NMa COa NMa COa Groupb Nightb Group  Nightb
SE 84.39 ˙ 10.57 92.86 ˙ 3.96 88.89 ˙ 9.82 95.29 ˙ 3.81 11.504** 12.087** 4.687*
WASO 52.97 ˙ 32.65 22.15 ˙ 17.58 33.56 ˙ 31.28 16.20 ˙ 17.95 16.404*** 26.196*** 16.895***
SL 34.56 ˙ 11.89 15.91 ˙ 8.45 28.94 ˙ 29.41 10.82 ˙ 4.88 11.717** 1.875, ns 0.113, ns
Stage 1 (%) 7.80 ˙ 6.68 5.33 ˙ 4.47 4.69 ˙ 3.31 2.75 ˙ 1.98 2.922† 6.057* 0.051, ns
Stage 2 (%) 54.10 ˙ 4.90 60.66 ˙ 6.63 58.55 ˙ 11.26 53.42 ˙ 6.36 0.424, ns 0.095, ns 6.350*
SWS (%) 12.94 ˙ 6.17 11.76 ˙ 5.14 17.25 ˙ 4.71 16.51 ˙ 5.43 0.012, ns 34.627*** 1.554, ns
REM (%) 25.85 ˙ 6.90 22.25 ˙ 5.64 29.13 ˙ 5.12 25.86 ˙ 4.39 3.167† 11.669** 0.025, ns
REM latency 105.06 ˙ 68.68 76.29 ˙ 27.83 77.19 ˙ 40.72 82.16 ˙ 37.47 0.724, ns 0.469, ns 1.616, ns
Groningen 6.54 ˙ 2.82 5.00 ˙ 2.65 3.77 ˙ 3.44 2.65 ˙ 2.32 6.059* 19.296*** 1.099, ns
Note. NM D nightmare sufferers group; CO D healthy controls group; SE D sleep efficiency; WASO D wake after sleep onset; SL D sleep latency; SWS D
slow-wave sleep; Groningen D Groningen Sleep Quality Scale; ns D p  :1.
aM ˙ SD. bChi-square.
*p < :05. **p < :01. ***p < :001. †p < :10.
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FIGURE 1 Sleep efficiency during the first and second night spent in the laboratory in nightmare sufferers
and healthy controls .M ˙ SD/.
(Nielsen et al., 2010), our NM group was characterized by an enhanced first-night effect.
Levin and Nielsen’s (2007) neurocognitive model explained this phenomenon by claiming
that the discomfort and inconvenience of the sleep laboratory setting affect the NM group
more due to their higher stress reactivity (Cernovsky, 1984; Coalson, 1995; Cook, Caplan,
& Wolowitz, 1990; Hartmann, 1984; Picchioni et al., 2002). Our results are controversial in
supporting this claim. Although the NM group scored higher than the CO group on anxiety and
depression scales, these variables did not explain the magnitude of the first-night effect—neither
FIGURE 2 Relative Stage-2 duration during the first and second night spent in the laboratory in nightmare
sufferers and healthy controls .M ˙ SD/.
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FIGURE 3 Box and whisker plots of Groningen Sleep Quality Scale scores of the two patient groups for
the nights spent in the laboratory and at home. Note. Higher scores indicate impaired sleep quality. Horizontal
bold lines D median; boxesD quartiles; minimum and maximum valuesD lower and upper whiskers; dots D
outliers.
expressed by the objective, nor by the subjective measures. One potential explanation of this
apparent inconsistency could emerge from the imprecise nature of psychometric instruments
in characterizing the sleep laboratory-related discomfort and stress reactivity of our NM par-
ticipants. Alternatively, these findings are in line with previous considerations (Spoormaker &
Montgomery, 2008), suggesting that nightmare disorder should be conceptualized as a specific
sleep disorder that is independent from comorbid psychopathological symptoms. It should also
be noted that the difference between the first-night effect of the two groups mostly stems from
a large baseline difference—namely, that the NM participants sleep much worse on the first
night. Severely impaired sleep quality at the first night in the NM group, compared to that of
the CO group, extends our previous results on a larger sample (Simor et al., 2012)—partly
overlapping with this sample—showing disturbed sleep architecture in NM participants based
on the recordings of the second night.
Our study—in contrast to other results (e.g., Moser et al., 2010)—also revealed a difference
in the participants’ subjective evaluations between the two consecutive nights, as reflected by
the scores obtained on the Groningen Sleep Quality Scale. Moreover, this score was related to
many objective sleep indexes in contrast to another study combining objective and subjective
sleep measures, which found disagreement between the two (Silva et al., 2007). This might
be attributed to the fact that, in this study, participants had to estimate specific parameters of
their sleep—for instance, sleep latency or sleep length—so the “report biases” referred to the
differences between the estimated and the exact values calculated from the polysomnographic
data. There are no estimation requirements in the Groningen Sleep Quality Scale: We calculated
an overall score about the subjective perception of the sleep quality based on yes–no answers
given by the participants. This fundamental difference in the subjective method can explain
the strong correlation we found between the data coming from the subjective and objective
measures.
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Along with the discussed theoretical contributions, our results may have practical conse-
quences as well. It has been suggested earlier that the first-night effect might not be limited
to the first night spent in the laboratory (Le Bon et al., 2001), which can question the validity
of the data recorded on the second night. When investigating different medical populations, a
pronounced first-night effect can cause the differences compared to the CO group. Our study
did not find this pattern regarding idiopathic NM participants given that—similar to the CO
group—the subjective score of the second night did not significantly differ from the score of
the night spent at home. Participants with nightmare disorder even had a tendency to sleep
better on the second night in the laboratory than at home, probably due to the partial sleep
deprivation arising from the low sleep efficiency and reduced SWS observed during first night
spent in the laboratory.
Our results showed that the Groningen Sleep Quality Scale is a valid tool to assess partic-
ipants’ baseline sleep quality (as measured at home). Thus, it might be used as an indicator
of whether sleep in the laboratory differs from normal home sleep. Due to the lack of data
available about the length of the first-night effect in specific medical conditions so far, the
practical implementation of this questionnaire in all medical procedures is questionable, but it
would contribute to the collection of valid—at least first-night effect free—objective sleep data.
We should note, however, that due to technical problems—most commonly during the first
night—we could only examine both nights’ recordings in a relatively small subset of our
participants. Because the statistical power of our analyses is relatively low, our findings should
be reproduced in subsequent experiments. Due to this small sample size, we could not exclude
outliers from the analysis that might pose further limitations to our results. Moreover, the
effects of the first night might influence sleep patterns on subsequent nights as well; therefore,
investigations involving three or more laboratory nights would shed more light on the extended
effects of the laboratory setting.
Despite these limitations, our results draw attention to the fact that, in contrast to everyday
practice—according to which the polysomnographic data recorded at the first night spent in
the laboratory has to be excluded (Mendels & Hawkins, 1967)—the analysis of the first night’s
sleep can provide valuable information. The differences between the sleep macrostructure of
the first and second night are not necessarily the same in different medical conditions; therefore,
future research about this phenomena might shed light on new diagnostic criteria.
NOTE
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